|
Name |
1,1-Cyclohexanedimethanol
|
| Molecular Formula | C8H16O2 | |
| IUPAC Name* |
[1-(hydroxymethyl)cyclohexyl]methanol
|
|
| SMILES |
C1CCC(CC1)(CO)CO
|
|
| InChI |
InChI=1S/C8H16O2/c9-6-8(7-10)4-2-1-3-5-8/h9-10H,1-7H2
|
|
| InChIKey |
ORLQHILJRHBSAY-UHFFFAOYSA-N
|
|
| Synonyms |
1,1-Cyclohexanedimethanol; 2658-60-8; [1-(hydroxymethyl)cyclohexyl]methanol; Cyclohexane-1,1-dimethanol; cyclohexane-1,1-diyldimethanol; NSC70173; 1,1-dimethylolcyclohexane; SCHEMBL15187; 1,1-di-hydroxymethylcyclohexane; DTXSID20949427; (Cyclohexane-1,1-diyl)dimethanol; (1-hydroxymethylcyclohexyl)methanol; ZINC1696148; Cyclohexane, 1,1-di-hydroxymethyl-; NSC-70173; AKOS017515623; AB89687; DS-020721; EN300-85223; A50718
|
|
| CAS | 2658-60-8 | |
| PubChem CID | 250594 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 144.21 | ALogp: | 1.1 |
| HBD: | 2 | HBA: | 2 |
| Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 40.5 | Aromatic Rings: | 1 |
| Heavy Atoms: | 10 | QED Weighted: | 0.614 |
| Caco-2 Permeability: | -4.338 | MDCK Permeability: | 0.00002300 |
| Pgp-inhibitor: | 0.002 | Pgp-substrate: | 0.001 |
| Human Intestinal Absorption (HIA): | 0.005 | 20% Bioavailability (F20%): | 0.023 |
| 30% Bioavailability (F30%): | 0.505 |
| Blood-Brain-Barrier Penetration (BBB): | 0.867 | Plasma Protein Binding (PPB): | 19.52% |
| Volume Distribution (VD): | 0.86 | Fu: | 76.32% |
| CYP1A2-inhibitor: | 0.406 | CYP1A2-substrate: | 0.341 |
| CYP2C19-inhibitor: | 0.047 | CYP2C19-substrate: | 0.672 |
| CYP2C9-inhibitor: | 0.032 | CYP2C9-substrate: | 0.081 |
| CYP2D6-inhibitor: | 0.034 | CYP2D6-substrate: | 0.45 |
| CYP3A4-inhibitor: | 0.058 | CYP3A4-substrate: | 0.203 |
| Clearance (CL): | 6.556 | Half-life (T1/2): | 0.677 |
| hERG Blockers: | 0.025 | Human Hepatotoxicity (H-HT): | 0.79 |
| Drug-inuced Liver Injury (DILI): | 0.023 | AMES Toxicity: | 0.018 |
| Rat Oral Acute Toxicity: | 0.006 | Maximum Recommended Daily Dose: | 0.073 |
| Skin Sensitization: | 0.085 | Carcinogencity: | 0.981 |
| Eye Corrosion: | 0.039 | Eye Irritation: | 0.977 |
| Respiratory Toxicity: | 0.274 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC001276 | ![]() |
0.311 | D0J0ZS | ![]() |
0.488 | ||
| ENC000592 | ![]() |
0.280 | D0CK3G | ![]() |
0.298 | ||
| ENC002918 | ![]() |
0.267 | D0O3FG | ![]() |
0.266 | ||
| ENC002922 | ![]() |
0.246 | D0P1UX | ![]() |
0.235 | ||
| ENC000251 | ![]() |
0.243 | D0D0GV | ![]() |
0.231 | ||
| ENC004216 | ![]() |
0.233 | D03CEF | ![]() |
0.214 | ||
| ENC000492 | ![]() |
0.217 | D07XJM | ![]() |
0.213 | ||
| ENC001222 | ![]() |
0.216 | D03DVJ | ![]() |
0.204 | ||
| ENC004836 | ![]() |
0.213 | D00HWO | ![]() |
0.200 | ||
| ENC005065 | ![]() |
0.213 | D0X9RG | ![]() |
0.198 | ||